WuXi Biologics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	3,356	3,400	4,420	3,388
Depreciation & Amortization	1,437	1,169	800.67	481.78
Other Amortization	24.43	-73.88	32.36	90.49
Loss (Gain) From Sale of Assets	-0.46	3.48	19.27	0.87
Loss (Gain) From Sale of Investments	91.72	-13.83	-379.44	-665.44
Stock-Based Compensation	1,216	1,274	1,234	531.92
Provision & Write-off of Bad Debts	151.78	319.97	258.53	156.67
Other Operating Activities	-258.43	-514.84	130.08	409.82
Change in Accounts Receivable	161.93	-1,038	-1,500	-1,441
Change in Inventory	201.85	442.46	-498.12	-783.19
Change in Accounts Payable	375.38	-162.34	-509.02	741.85
Change in Unearned Revenue	-1,313	-317.2	1,633	1,071
Change in Other Net Operating Assets	-226.69	178.41	-100.14	-551.77
Operating Cash Flow	5,217	4,668	5,542	3,431
Operating Cash Flow Growth	11.77%	-15.77%	61.51%	82.39%
Capital Expenditures	-3,930	-4,046	-5,868	-6,508
Sale of Property, Plant & Equipment	87.33	196.86	20.13	80.86
Cash Acquisitions	-	-	-131.49	-2,181
Sale (Purchase) of Intangibles	-	-10	-	-
Investment in Securities	-387.97	596.39	-253.24	-1,428
Other Investing Activities	288.56	34.07	324.74	433.9
Investing Cash Flow	-3,942	-3,228	-5,908	-9,602
Long-Term Debt Issued	1,129	1,097	2,389	675.28
Total Debt Issued	1,129	1,097	2,389	675.28
Long-Term Debt Repaid	-818.68	-1,916	-2,684	-822.11
Total Debt Repaid	-818.68	-1,916	-2,684	-822.11
Net Debt Issued (Repaid)	309.96	-818.45	-295.02	-146.83
Issuance of Common Stock	19.39	26.16	36.18	11,035
Repurchase of Common Stock	-1,766	-916.92	-2,804	-2,517
Other Financing Activities	-1,314	3,670	471.7	-161.91
Financing Cash Flow	-2,750	1,961	-2,592	8,209
Foreign Exchange Rate Adjustments	83.98	-125.99	350.11	-131.5
Net Cash Flow	-1,391	3,275	-2,608	1,908
Free Cash Flow	1,288	622.14	-326.72	-3,077
Free Cash Flow Growth	106.97%	-	-	-
Free Cash Flow Margin	6.89%	3.65%	-2.14%	-29.90%
Free Cash Flow Per Share	0.30	0.14	-0.07	-0.70
Cash Interest Paid	200.61	217.28	108.24	83.2
Cash Income Tax Paid	1,092	782.53	585.66	349.99
Levered Free Cash Flow	-2,296	-320.31	-594.39	-3,720
Unlevered Free Cash Flow	-2,198	-221.25	-554.16	-3,696
Change in Working Capital	-800.5	-896.35	-974.47	-963.33

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.